has received honoraria from Boehringer Ingelheim, Eli Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, AbbVie, Janssen, Bayer, Prometic, Bristol Myers Squibb, Maze, Gilead, CSL-Behring, Otsuka, Novartis, Youngene and Novo Nordisk and has received operational funding for clinical trials from Boehringer Ingelheim, Eli Lilly, Merck, Janssen, Sanofi, AstraZeneca, CSL-Behring and Novo Nordisk
Incorporating a balanced diet, regular physical activity, and behavioral changes enhances the benefits of these medications and supports long-term weight loss and maintenance
These solutions include oral and sublingual options that may help reduce hunger and increase satiety, making portion control and maintaining a healthy diet easier
8 , e178e182 (2014)
Availability Wegovy is already available, while Mounjaro is still being introduced in some UK clinics